Skip to main content

Advertisement

Table 1 Distribution of variables for cardiovascular outcomes of interest

From: Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)

Variables Cardiovascular outcomes of interest p-value
Total N = 1169 CVD N = 148 No CVD N = 1013
Female sex, n (%) 609 (53.3%) 57 (38.5%) 550 (55.7%) < 0.001
Age (years), mean (± SD) 40.0 (± 16.7) 58.5 (± 13.7) 37.3 (± 15.4) < 0.001
Age (years), median (IQR) 37.0 (24.9-52.0) 59.0 (49.0-68.2) 33.8 (23.9-47.2) < 0.001
Diabetes duration (years), mean (SD) 19.2 (± 14.4) 34.8 (± 15.5) 17.1 (± 12.8) < 0.001
Diabetes duration (years), median (IQR) 16.0 (8.0-27.0) 35.0 (24.5-45.0) 15.0 (8.0-24.0) < 0.001
Diabetes duration (≥ 20.0 years), n (%) 476 (41.3%) 121 (84.0%) 354 (35.4%) < 0.001
HbA1c (%), mean (± SD) 8.5 (± 1.8) 8.6 (± 1.5) 8.5 (± 1.9) 0.386
HDL-Ca, mean (± SD) 1.53 (± 0.54) 1.35 (± 0.42) 1.56 (± 0.56) < 0.001
LDL-Ca, mean (± SD) 2.55 (± 0.95) 2.15 (± 0.82) 2.62 (± 0.95) < 0.001
Total-Ca, mean (± SD) 4.73 (± 1.09) 4.18 (± 1.12) 4.83 (± 1.06) < 0.001
Triglyceridesa, mean (± SD) 1.37 (± 1.42) 1.54 (± 1.84) 1.34 (± 1.34) 0.190
Systolic BPb, mean (± SD) 124 (± 17) 132 (± 21) 123 (± 16) < 0.001
Diastolic BPb, mean (± SD) 74 (± 10) 72 (± 10) 74 (± 10) 0.073
BMI categories, n (%) (kg/m2) 0.372
 < 18.5 20 (2.0%) 4 (3.2%) 15 (1.7%)  
 18.5 to < 25 419 (41.6%) 51 (40.5%) 365 (41.8%)  
 25 to < 30 315 (31.3%) 34 (27.0%) 279 (31.9%)  
 ≥ 30 253 (25.1%) 37 (29.4%) 215 (24.6%)  
Ever smoked, n (%) 397 (38.5%) 86 (64.2%) 309 (34.6%) < 0.001
Albuminuria, n (%) 220 (31.1%) 46 (47.9%) 174 (28.6%) < 0.001
eGFRc, mean (± SD) 97 (± 28) 71 (± 29) 101 (± 25) < 0.001
Antihypertensive Rx, n (%) 320 (28.1%) 105 (72.9%) 214 (21.7%) < 0.001
Lipid lowering Rx, n (%) 342 (29.7%) 110 (75.3%) 232 (23.2%) < 0.001
Retinopathy, n (%) 284 (24.7%) 82 (56.2%) 202 (20.2%) < 0.001
  1. Rx: treatment
  2. ammol/L, b mmHg, c mL/min/1.73 m2